US FDA Offers More Advice On Mid-Trial Changes For Pandemic-Impacted Studies

 
• By Sue Sutter
  
Shetland Sheepdog in agility slalom. Sized to fit for cover image on popular social media site.
High-level regulatory guidance is allowing sponsors to take an agile approach to mitigating trial impacts. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D